MDA Advocacy Institute: Unlocking Treatment Development for Rare Neuromuscular Diseases

Join MDA and grassroot advocates as they discuss why some treatments are swiftly approved by the FDA while others take much longer or fail altogether, including the incentives, policies, programs, and more that have been proven to lead to successful drug development efforts. They’ll also discuss some efforts to strengthen, and others to weaken, these programs and how you can help. Plus, they’ll take your questions.

Pre-Registration is required